Top all-time · #15611
Recursion
Company blog · recursion.com/newsprogrammingscience
Recursion is the company blog at recursion.com, writing about programming and science. Since 2010, 5 different Hacker News readers have linked it 6 times. No feed was found, so read it on the site itself.
Too few sampled comments (4) to say how often HN recommends it.?
Why HN links it
Linked pages from Recursion's AI drug discovery site. The comments discuss biotech job roles, drug development costs, biotech salaries, and an interpolique page on preventing string injection attacks. None judge the writing.
Summarised by Claude from a sample of 4 HN comments that link here. Each comment is marked recommending, critical or neutral (citing without judging); how this works.
Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us today!
What Hacker News says?
Hm, we must be thinking of slightly different things. Lots of biotech companies have pure software positions. Here are some examples of software positions that require no scientific background whatsoever: https://boards.greenhouse.io/invitae/jobs/4196489?gh_jid=419... https://www.recursion.com/careers?gh_jid=3992017 "A biology background is not necessary, but intellectual curiosity is a must!" https://ekgn.fa.us6.or…
Comment linking /careers?gh_jid=3992017
on “I should have loved biology”Submitted Interpolique: A new mechanism for preventing string injections as a story · 4 points
HN discussionThis is essentially true. Pharma is incredibly expensive (for lots of different reasons), with R&D taking up a huge portion of those costs. So yes, it's safe to assume that part of the accounting around those published costs in the billions are all of the failed candidates that never even made it to trials (the failure rate varies depending on the area of biology and the type of drug, but it's generally around 9 out…
Comment linking /
on “Cost of developing new drugs may be lower than industry claims: trial”Submitted Evaluating Python Dependency Managers as a story · 2 points
HN discussionThere are a lot of comments in this thread discussing biotech salaries. They're not universally true. Source: I'm the VP of data science at Recursion, a biotech company focused on drug discovery, so I manage or have visibility into hiring in the domains that most people on this site would likely be interested in. The biotech industry (which is made up of at least three rather different verticals: tools, diagnostics,…
Comment linking /careers
on “Be in a field where tech is the limit”This seems a good time to mention interpolique: http://recursion.com/interpolique.html I'm curious what people here think of that idea, ie, preventing string injection attacks at the language level.
Comment linking /interpolique.html
on “Persistent XSS on Twitter.com”